Showing results (501-510 of 632) with videos related to
Sort By:
Pageof 64
Human Vaccines|February 23, 2011
Persistence of immune responses after a single dose of Novartis meningococcal serogroup A, C, W-135 and Y CRM-197 conjugate vaccine (Menveo®) or Menactra® among healthy adolescentsChristopher J Gill, Roger Baxter, Alessandra Anemona, et al.Human Vaccines|January 27, 2011
Safety and tolerability of bivalent HPV vaccine: an Italian post-licensure studyRoberto Gasparini, Paolo Bonanni, Miriam Levi, et al.Human Vaccines|January 27, 2011
13-valent pneumococcal conjugate vaccine immune sera protects against pneumococcal serotype 1, 3, and 5 bacteremia in a neonatal rat challenge modelPhilip Fernsten, Kathryn W Mason, Xinhong Yu, et al.Human Vaccines|February 1, 2011
Cost of acute hospitalization and post-discharge follow-up care for meningococcal disease in the USKeith L Davis, Derek Misurski, Jacqueline M Miller, et al.Human Vaccines|February 1, 2011
Non-specific and sex-differential effects of routine vaccines: what evidence is needed to take these effects into consideration in low-income countries?Peter Aaby, Christine S BennHuman Vaccines|February 11, 2011
The humoral response to Gardasil over four years as defined by total IgG and competitive Luminex immunoassayDarron R Brown, Suzanne M Garland, Daron G Ferris, et al.Human Vaccines|February 11, 2011
Co-administration of a novel Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine does not interfere with the immune response to antigens contained in infant vaccines routinely used in the United StatesGary S Marshall, Colin D Marchant, Mark Blatter, et al.Human Vaccines|December 24, 2010
Meningococcal glycoconjugate vaccinesRoberto Gasparini, Donatella PanattoHuman Vaccines|February 3, 2011
Assessment of the safety, tolerability and kinetics of the immune response to A/H1N1v vaccine formulations with and without adjuvant in healthy pediatric subjects from 3 through 17 years of ageAdriano Arguedas, Carolina Soley, Arturo Abdelnour, et al.Human Vaccines|February 16, 2011
Folate receptor α: a storied past and promising future in immunotherapyGuy T Clifton, Alan K Sears, Kevin S Clive, et al.Pageof 64